<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316022/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316022</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cells</name><description>BCL11A is a transcription factor crucial for neurodevelopment and hematopoiesis. It regulates the developmental switch from fetal hemoglobin (HbF) to adult hemoglobin and is a major therapeutic target for sickle cell disease and b-thalassemia. We investigated BCL11A functions in human erythrocyte precursor HUDEP-2 cells. We treated HUDEP-2 cells (which normally express adult hemoglobin) with inhibitors targeting epigenetic silencing marks - DNA methylation and histone H3 lysine 27 methylation. All treatments, individually or in combination, increased HbF expression to varying degrees.</description><dates><publication>2026/04/14</publication></dates><accession>GSE316022</accession><cross_references><GSM>GSM9443391</GSM><GSM>GSM9443392</GSM><GSM>GSM9443393</GSM><GSM>GSM9443394</GSM><GPL>34284</GPL><GSE>316022</GSE><taxon>Homo sapiens</taxon><PMID>[41822826]</PMID></cross_references></HashMap>